abstract |
The present invention relates to novel pyrazolopyridine-derived heterocyclic compounds which induce Fibroblast Growth Factors (or FGFRs) receptor dimerization of the general formula: M -LM wherein M or M, which are identical or different, each represent independently of each other a monomer unit M and L represents a linking group which binds Mi and M covalently with the monomer unit which follows: Their preparation process and their therapeutic application. |